Clinical Trials in the Category "Lymphoma, Non-Hodgkin"

Drug Intervention Trials that are Recruiting

Study Title	Principal Investigator	Disease Category

A Phase 2 Open Label Trial of SGN-35 for Systemic Anaplastic Large Cell Lymphoma	Michael Link	Lymphoma Lymphoma, Non-Hodgkin

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-Cell Lymphoma	Youn H Kim	Lymphoma, T-Cell Lymphoma, T-Cell, Cutaneous

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers	Sandra Jeane Horning	Lymphoma, Non-Hodgkin Lymphoproliferative Disorders

Donor Stem Cell Transplant in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma After First Complete Remission	Ginna Laport	Lymphoma Lymphoma, Non-Hodgkin

Ph II, Multicenter, Simon 2-Stage of R788 For Relapsed or Refractory T-Cell Lymphoma	Ranjana Hira Advani	Lymphoma, T-Cell

Phase I Dose-Escalation Study of Btk Inhibitor PCI-32765 in Recurrent B Cell Lymphoma	Ranjana Hira Advani	Lymphoma, Non-Hodgkin Leukemia, Lymphocytic, Chronic Lymphoma, Small-Cell

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies	Steven Edward Coutre	Lymphoma, Non-Hodgkin Leukemia, Lymphocytic, Chronic

Safety and Efficacy of RAD001 in Patients With Velcade® Refractory Mantle Cell Lymphoma	Ranjana Hira Advani	Lymphoma, Mantle-Cell

Ph II of Single-Agent Enzastaurin for Relapsed Cutaneous T-Cell Lymphoma	Youn H Kim	Lymphoma, T-Cell

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients	Steven Edward Coutre	Leukemia Leukemia, Myeloid Leukemia, Myelocytic, Acute Lymphoma, T-Cell, Cutaneous

A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Second-Line Treatment of Patients With DLBCL	Ranjana Hira Advani	Lymphoma, Diffuse Lymphoma, B-Cell Lymphoma, Non-Hodgkin

Study of Pralatrexate and Gemcitabine With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Lymphoproliferative Malignancies	Ranjana Hira Advani	Lymphoma, Hodgkin Disease Hodgkin Disease Lymphoma, Non-Hodgkin

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma	Youn H Kim	Lymphoma, T-Cell

Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma	Youn H Kim	Lymphoma, T-Cell, Cutaneous

Study of Bexxar Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma	Susan J Knox	Lymphoma, Non-Hodgkin

Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A	Youn H Kim	Lymphoma, T-Cell, Cutaneous

Phase II study of Atorvastatin safety and antitumor effects in non-Hodgkin's Lymphoma	Dean Felsher	Leukemia Lymphoma, Non-Hodgkin

Phase II Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma	Susan J Knox	Lymphoma, Non-Hodgkin Lymphoma, Large-Cell, Diffuse

Phase II Poor Risk Diffuse Large B-cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT)	Sandra Jeane Horning	Lymphoma, B-Cell

Clinical Trial of PXD101 in Patients With T-Cell Lymphomas	Ranjana Hira Advani	Lymphoma, T-Cell

Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome	Youn H Kim	Lymphoma Lymphoma, Non-Hodgkin

Device Intervention Trials that are Recruiting

Study Title	Principal Investigator	Disease Category

Phase II Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides	Richard T. Hoppe	Mycosis Fungoides

Other Trials that are Recruiting

Study Title	Principal Investigator	Disease Category

Ph II of Non-myeloablative Allgnc Trnsplnt Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma	Wen-Kai Weng	Sezary Syndrome Mycoses Lymphoma, T-Cell, Cutaneous

Phase I/II of a CpG-Activated Whole Cell Vaccine Followed by Autologous “Immunotransplant” for MCL	Ronald Levy	Lymphoma, Mantle-Cell

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease	Ronald Levy	Lymphoma, Non-Hodgkin

Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma	Wen-Kai Weng	Lymphoma, Non-Hodgkin

Research Sample Repository for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation	Robert S Negrin Judith Anne Shizuru	Leukemia, Myeloid Lymphoma, Non-Hodgkin Multiple Myeloma

NMDP Research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation	David Miklos	Lymphoma, Non-Hodgkin Leukemia, Lymphocytic Multiple Myeloma

Trials not Recruiting

Study Title	Principal Investigator	Disease Category

Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated w/RCHOP +/- XRT *(No longer recruiting)*	Kristen N. Ganjoo	Lymphoma Lymphoma, Non-Hodgkin

An Open Label Six Month Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.04% Ointment Formulation in Patients With Stage I or IIA Mycosis Fungoides (MF) Who Have Completed an Initial 12 Month Treatment With Nitrogen Mustard 0.02% But Without a Complete Response *(inv )*	Youn H Kim	Mycosis Fungoides

Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma *(No longer recruiting)*	Kristen N. Ganjoo	Lymphoma, Non-Hodgkin

Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides *(No longer recruiting)*	Youn H Kim	Mycosis Fungoides

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-Cell Lymphoma *(No longer recruiting)*	Youn H Kim	Mycosis Fungoides Lymphoma, T-Cell, Cutaneous

Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined with Local Radiation for Patients with Recurrent Mycosis Fungoides. *(Terminated)*	Ronald Levy	Mycosis Fungoides

Phase I/II CPG 7909 + Local XRT in Recurrent Low-Grade Lymphomas *(No longer recruiting)*	Ronald Levy	Lymphoma, Non-Hodgkin

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma *(No longer recruiting)*	Wen-Kai Weng	Lymphoma, Non-Hodgkin

Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma *(No longer recruiting)*	Robert S Negrin	Lymphoma, Non-Hodgkin

Allo BMT in Advanced Leukemia or High Grade Lymphoma *(No longer recruiting)*	Robert Lowsky	Lymphoma, Non-Hodgkin

A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma *(No longer recruiting)*	Ranjana Hira Advani	Lymphoma, T-Cell, Peripheral

Trial of AVN-944 in Patients With Advanced Hematologic Malignancies *(Completed)*	Steven Edward Coutre	Leukemia Waldenstrom Macroglobulinemia Lymphoma, Non-Hodgkin Multiple Myeloma

Study of SGN-40 (Anti-huCD40 mAb) in Patients With Relapsed Diffuse Large B-Cell Lymphoma *(No longer recruiting)*	Ranjana Hira Advani	Lymphoma, B-Cell

Rituximab, Combination Chemotherapy, and Bortezomib in Treating Patients With Untreated Mantle Cell Lymphoma *(No longer recruiting)*	Sandra Jeane Horning	Lymphoma Lymphoma, Mantle-Cell

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma *(Completed)*	Sandra Jeane Horning	Lymphoma, Non-Hodgkin

A Dose and Schedule Finding Trial With AMG 531 for CIT in Adults With Lymphoma *(Completed)*	Ranjana Hira Advani	Lymphoma Thrombocytopenia Lymphoma, Non-Hodgkin

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma *(Terminated)*	Ronald Levy	Lymphoma, Non-Hodgkin Lymphoma, Follicular

Study of YM155 in Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Subjects *(Terminated)*	Sandra Jeane Horning	Lymphoma, B-Cell Reticuloendotheliosis Histiocytosis Lymphoma, Large-Cell, Diffuse

The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Clinical Trials in the Category "Lymphoma, Non-Hodgkin"

Drug Intervention Trials that are Recruiting

Device Intervention Trials that are Recruiting

Other Trials that are Recruiting

Trials not Recruiting

Navigation for This Section: Clinical Trials

Site Navigation:

Stanford Medicine Resources:

Footer Links:

Clinical Trials in the Category "Lymphoma, Non-Hodgkin"

Drug Intervention Trials that are Recruiting

Device Intervention Trials that are Recruiting

Other Trials that are Recruiting

Trials not Recruiting

You are Here:

Navigation for This Section: Clinical Trials

Site Navigation:

Stanford Medicine Resources:

Footer Links: